- Category
- Small (2024-25)
- Udyam number
- UDYAM-MH-18-0067971

Nivian Pharma LLP
About Nivian Pharma LLP
Data last updated:
Nivian Pharma LLP is a limited liability partnership (LLP) based in Thane, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 02 August 2018 and has been in existence for over 8 years.
The LLP is registered with the Registrar of Companies (ROC), Mumbai, under LLPIN AAN-0852. Its GSTIN is 27AAPFN6671B1Z1 (Maharashtra).
The LLP has a total obligation of contribution of ₹43,000. It is led by designated partners Nilesh Namdev Auti and Anjali Ajit Deval.
Its latest statement of accounts is for the year ended 31 March 2024. The registered office is at 605 6th Floor Omega Business Park, Thane, Maharashtra.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹14.8 Cr, a growth of 49% compared to the previous year. For the same year it recorded a net profit of ₹87.46 Lakh (net margin 5.9%) and EBITDA of ₹61.5 Lakh (EBITDA margin 4.2%).
The LLP has about 40 employees on its provident fund (EPFO) records.
As per MCA filings, the LLP has open charges of ₹2 Cr and satisfied charges of ₹86.49 Lakh on record.
Nivian Pharma LLP is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-18-0067971).
Company details
Recognitions & Rankings of Nivian Pharma
Contact details
Nivian Pharma LLP's registered office is in Thane, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressUnit No. 605 6th Floor Omega Business Park, Plot No. A – 271 & A – 298 Road No. 33, Thane, Maharashtra, India – 400604
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Nivian Pharma LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nivian Pharma LLP
FY 2024 filings availableNivian Pharma LLP reported revenue of ₹14.8 Cr (up 49% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 49% in the latest year. EBITDA fell 52% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹87.46 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 5.9% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Nivian Pharma LLP, buy the company report.
Designated partners of Nivian Pharma LLP
Nivian Pharma has 2 current designated partners and 3 former designated partners. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nilesh Namdev Auti Also directs: Nivian Life Sciences Private Limited | Designated Partner | 23 Sep 2021 | 5 Years 1 Months | Current |
| Anjali Ajit Deval Also directs: Clara Ventures LLP, Anjali & Ananya Fertility LLP, Nivian Life Sciences Private Limited and 2 more | Designated Partner | 27 Feb 2024 | 2 Years 8 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Dec 2021 | 100507925 | Hdfc Bank Limited | ₹2 Cr | Open | |
| 07 Nov 2022 | 100652488 | Axis Finance Limited | ₹86.49 Lakh | Satisfied |
To see the full charge records of Nivian Pharma LLP, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Nivian Pharma LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nivian Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Nivian Pharma LLP has a workforce of 40 employees on its EPFO records as of Jul 2024, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2024-25 | 40 |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 |
To see the full employee and EPFO history of Nivian Pharma LLP, buy the company report.
GST
Nivian Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAPFN6671B1Z1 | Maharashtra | Active | 20 Feb 2019 |
To see the full GST registrations and return filing status of Nivian Pharma LLP, buy the company report.
Recent activity
Nivian Pharma LLP has 5 designated partner changes on record since 2021: 2 appointments and 3 cessations. The latest: Anjali Ajit Deval was appointed as Designated Partner on 27 Feb 2024.
Frequently asked questions
Nivian Pharma is an active limited liability partnership based in Thane, Maharashtra, India. The LLP works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 02 August 2018 (8+ years old) and is registered under LLPIN AAN-0852.
Nivian Pharma has 2 current designated partners:
- Nilesh Namdev Auti - Designated Partner
- Anjali Ajit Deval - Designated Partner
The latest financial statements of Nivian Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 31 March 2024. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Nivian Pharma is 27AAPFN6671B1Z1, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Nivian Pharma is AAN-0852. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Nivian Pharma was incorporated on 02 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Mumbai.
Anjali Ajit Deval was appointed as Designated Partner on 27 Feb 2024. Riken Hitendra Gala ceased to be Designated Partner on 27 Feb 2024. Anjali Ajit Deval ceased to be Partner on 26 Feb 2024. Nivian Pharma has 5 designated partner changes on record in total.
Yes, Nivian Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-MH-18-0067971).
The registered office of Nivian Pharma is at Unit No. 605 6th Floor Omega Business Park, Plot No. A – 271 & A – 298 Road No. 33, Thane, Maharashtra, India – 400604.
Nivian Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

